138 related articles for article (PubMed ID: 24662794)
1. [Molecular mechanisms regulating metastasis of cancer cells with special emphasis on rhabdomyosarcoma].
Tarnowski M; Grymuła K; Tkacz M; Czerewaty M; Poniewierska-Baran A; Ratajczak MZ
Postepy Hig Med Dosw (Online); 2014 Mar; 68():258-70. PubMed ID: 24662794
[TBL] [Abstract][Full Text] [Related]
2. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
3. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines.
Giannattasio S; Megiorni F; Di Nisio V; Del Fattore A; Fontanella R; Camero S; Antinozzi C; Festuccia C; Gravina GL; Cecconi S; Dominici C; Di Luigi L; Ciccarelli C; De Cesaris P; Riccioli A; Zani BM; Lenzi A; Pestell RG; Filippini A; Crescioli C; Tombolini V; Marampon F
J Endocrinol Invest; 2019 Feb; 42(2):183-197. PubMed ID: 29790086
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of impaired differentiation in rhabdomyosarcoma.
Keller C; Guttridge DC
FEBS J; 2013 Sep; 280(17):4323-34. PubMed ID: 23822136
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
6. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound.
Cen L; Hsieh FC; Lin HJ; Chen CS; Qualman SJ; Lin J
Br J Cancer; 2007 Sep; 97(6):785-91. PubMed ID: 17848913
[TBL] [Abstract][Full Text] [Related]
7. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
9. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895
[TBL] [Abstract][Full Text] [Related]
10. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
11. DNA repair systems in rhabdomyosarcoma.
Tsioli PG; Patsouris ES; Giaginis C; Theocharis SE
Histol Histopathol; 2013 Aug; 28(8):971-84. PubMed ID: 23516236
[TBL] [Abstract][Full Text] [Related]
12. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
[TBL] [Abstract][Full Text] [Related]
13. Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo.
Tarnowski M; Tkacz M; Zgutka K; Bujak J; Kopytko P; Pawlik A
BMC Cancer; 2017 Aug; 17(1):532. PubMed ID: 28793874
[TBL] [Abstract][Full Text] [Related]
14. The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.
Strahm B; Durbin AD; Sexsmith E; Malkin D
Clin Exp Metastasis; 2008; 25(1):1-10. PubMed ID: 17768666
[TBL] [Abstract][Full Text] [Related]
15. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
[TBL] [Abstract][Full Text] [Related]
16. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
17. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H
Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748
[TBL] [Abstract][Full Text] [Related]
18. MiRNAs as Players in Rhabdomyosarcoma Development.
Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
[TBL] [Abstract][Full Text] [Related]
19. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]